Compare HCA Health Inc (HCA) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Jumia Technologies AG - ADR — how do they compare? HCA Health Inc trades at $410.76 (market cap $89.08B), while Jumia Technologies AG - ADR trades at $6.33 (market cap $719.58M). The key difference: HCA Health Inc is far larger — about 123.8× Jumia Technologies AG - ADR's market cap, and HCA Health Inc pays a 0.76% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.
| HCA | JMIA | |
|---|---|---|
Market Cap | $89.08B | $719.58M |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $14.60 |
52-Week Low | $361.32 | $5.69 |
Enterprise Value | $139.62B | $666.68M |
Dividend Yield | 0.76% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $414.03, up 0.16% today, with strong technical momentum as price sits above key support levels. The company demonstrates solid fundamentals with Q2 2026 earnings beating estimates, revenue growth to $75.6B in 2025, and consistent dividend payments. Recent management appointments signal strategic focus on clinical operations and ambulatory services.
HCA presents a compelling investment case with attractive valuation (P/E 13.8), analyst consensus price target of $449.93 (8.7% upside), and strong institutional support. However, risks include ongoing legal investigations, rising expenses impacting margins, and high debt levels at 80.9% debt-to-asset ratio that could constrain financial flexibility.
JMIA trades at $6.00, down 3.07% today, with a bearish technical signal. The company shows improving fundamentals with revenue growth to $189M in 2025 and narrowing losses, though it remains unprofitable with a -30.79% net margin. Analyst sentiment is positive with 71% buy ratings, supported by progress toward Q4 2026 breakeven targets and recent $50M capital raise.
The path to profitability remains the key investment thesis, with management targeting 2027 EBITDA breakeven. Risks include persistent cash burn, competitive e-commerce landscape, and execution challenges in African markets. The stock offers speculative upside if turnaround continues but carries significant operational risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
